AMRI and Cystic Fibrosis Foundation Launch Major Research Col... ( Total Value Could Rea...)

AMRI and Cystic Fibrosis Foundation Launch Major Research Collaboration

Date:10/4/2007

Total Value Could Reach Up to $23.7 Million

ANAHEIM, Calif. and ALBANY, N.Y., Oct. 4 /PRNewswire-USNewswire/ -- AMRI (Nasdaq: AMRI) and the Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit affiliate of the Cystic Fibrosis Foundation, announced today a four-year research collaboration, worth up to $23.7 million, aimed at identifying novel treatments that address the core defect in cystic fibrosis.

The agreement calls for AMRI to screen its natural products-based libraries to find compounds that improve the function of the defective protein in CF, known as the Cystic Fibrosis Transmembrane conductance Regulator (CFTR). AMRI will also conduct an integrated drug discovery program -- including chemistry and in vitro biology -- on promising compounds that may emerge from the screening program. Should any compounds identified under the agreement progress into preclinical or clinical testing, AMRI has the option to provide chemical development and GMP manufacturing services to CFFT on those compounds.

The announcement is being made in conjunction with the 21st Annual North American Cystic Fibrosis Conference in Anaheim, Calif.

"With this collaboration, we are proving once again that we will explore every promising avenue to find new therapies for people with CF," said Robert J. Beall, Ph.D, president and CEO of the Cystic Fibrosis Foundation. "We are excited about the potential of AMRI's cutting-edge natural products capabilities to complement our existing small molecule drug discovery strategy."

CFFT is exploring the promise of natural products in an effort to increase the number and diversity of chemicals available to improve the function of the defective CFTR pr
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Gene Therapy For Cystic Fibrosis
2. Antiparasitic Drug Effective In Reducing Seizures In Neurocysticercosis Patients
3. Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option
4. The Use Of Colistin To Treat Cystic Fibrosis Questioned
5. Approval for DNA test to detect cystic fibrosis
6. Cystic fibrosis patients may require a new treatment for bacterial infection
7. Developmental Origins of Polycystic Ovarian Syndrome
8. Roots of polycystic ovarian syndrome traced to mother’s wom
9. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
10. Treatment for Cystic Fibrosis in the future
11. Polycystic Ovary In Women May Raise Liver Disease

Post Your Comments:

AMRI and Cystic Fibrosis Foundation Launch Major Research Col...( Total Value Could Rea...),Health